September 29, 2022

Volume XII, Number 272

Kathleen M. Sanzo

Kathleen M. Sanzo centers her practice on regulatory and compliance issues connected to products regulated by the US Food and Drug Administration (FDA). She leads and counsels clients on matters relating to prescription, OTC drug, and biotechnology products clinical testing; food, dietary supplement, and cosmetic product manufacture, approval, marketing, and distribution; device promotion and labeling issues; food, drug, and device compliance matters; and all consumer product issues regulated by the US Consumer Product Safety Commission (CPSC) and state enforcement agencies.​​

As the FDA practice leader, Kathleen represents clients in the pharmaceuticals & biotechnology, food and dietary supplements, cosmetics, consumer products, consumer protection safety, advertising, cosmetics, drugs, and medical industries.

Articles in the National Law Review database by Kathleen M. Sanzo